These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 1386145)

  • 41. Guanine nucleotides are competitive inhibitors of N-methyl-D-aspartate at its receptor site both in vitro and in vivo.
    Baron BM; Dudley MW; McCarty DR; Miller FP; Reynolds IJ; Schmidt CJ
    J Pharmacol Exp Ther; 1989 Jul; 250(1):162-9. PubMed ID: 2545857
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Kynurenic acid analogues with improved affinity and selectivity for the glycine site on the N-methyl-D-aspartate receptor from rat brain.
    Foster AC; Kemp JA; Leeson PD; Grimwood S; Donald AE; Marshall GR; Priestley T; Smith JD; Carling RW
    Mol Pharmacol; 1992 May; 41(5):914-22. PubMed ID: 1375317
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Regionally distinct N-methyl-D-aspartate receptors distinguished by quantitative autoradiography of [3H]MK-801 binding in rat brain.
    Sakurai SY; Penney JB; Young AB
    J Neurochem; 1993 Apr; 60(4):1344-53. PubMed ID: 8095974
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High-affinity binding of [3H]desipramine to rat brain: a presynaptic marker for noradrenergic uptake sites.
    Rehavi M; Skolnick P; Brownstein MJ; Paul SM
    J Neurochem; 1982 Apr; 38(4):889-95. PubMed ID: 7062040
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A study of cortical and hippocampal NMDA and PCP receptors following selective cortical and subcortical lesions.
    Maragos WF; Greenamyre JT; Chu DC; Penney JB; Young AB
    Brain Res; 1991 Jan; 538(1):36-45. PubMed ID: 1850317
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of graded hypoxia on the high-affinity CPP binding site of the NMDA receptor in the cerebral cortex of newborn piglets.
    Fritz KI; Zanelli S; Mishra OP; Delivoria-Papadopoulos M
    Brain Res; 2001 Feb; 891(1-2):266-73. PubMed ID: 11164831
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Somatostatin-induced activation and up-regulation of N-methyl-D-aspartate receptor function: mediation through calmodulin-dependent protein kinase II, phospholipase C, protein kinase C, and tyrosine kinase in hippocampal noradrenergic nerve endings.
    Pittaluga A; Feligioni M; Longordo F; Arvigo M; Raiteri M
    J Pharmacol Exp Ther; 2005 Apr; 313(1):242-9. PubMed ID: 15608072
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Stimulation of noradrenaline release in human cerebral cortex mediated by N-methyl-D-aspartate (NMDA) and non-NMDA receptors.
    Fink K; Schultheiss R; Göthert M
    Br J Pharmacol; 1992 May; 106(1):67-72. PubMed ID: 1380384
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Regional variations in [3H]MK801 binding to rat brain N-methyl-D-aspartate receptors.
    Reynolds IJ; Palmer AM
    J Neurochem; 1991 May; 56(5):1731-40. PubMed ID: 1826521
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evidence for heterogenous glycine domains but conserved multiple states of the excitatory amino acid recognition site of the NMDA receptor: regional binding studies with [3H]glycine and [3H]L-glutamate.
    O'Shea RD; Manallack DT; Conway EL; Mercer LD; Beart PM
    Exp Brain Res; 1991; 86(3):652-62. PubMed ID: 1684753
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification and characterization of a high-affinity glutamate-controlled TCP binding site in rat brain postsynaptic densities.
    Foucaud B; Gombos G
    Eur J Pharmacol; 1990 Dec; 189(6):355-62. PubMed ID: 1981559
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characterization of the binding of [3H]L-689,560, an antagonist for the glycine site on the N-methyl-D-aspartate receptor, to rat brain membranes.
    Grimwood S; Moseley AM; Carling RW; Leeson PD; Foster AC
    Mol Pharmacol; 1992 May; 41(5):923-30. PubMed ID: 1375318
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterization of the binding of radioligands to the N-methyl-D-aspartate, phencyclidine, and glycine receptors in buffy coat membranes.
    Jones SM; Snell LD; Johnson KM
    J Pharmacol Methods; 1989 Apr; 21(2):161-8. PubMed ID: 2541283
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacological modifications of the neurotoxic action of the noradrenaline neurotoxin DSP4 on central noradrenaline neurons.
    Hallman H; Jonsson G
    Eur J Pharmacol; 1984 Aug; 103(3-4):269-78. PubMed ID: 6237924
    [TBL] [Abstract][Full Text] [Related]  

  • 55. N-methyl-D-aspartic acid (NMDA) and non-NMDA receptors regulating hippocampal norepinephrine release. I. Location on axon terminals and pharmacological characterization.
    Pittaluga A; Raiteri M
    J Pharmacol Exp Ther; 1992 Jan; 260(1):232-7. PubMed ID: 1370540
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Excessive release of [3H]noradrenaline and glutamate in response to simulation of ischemic conditions in rat spinal cord slice preparation: effect of NMDA and AMPA receptor antagonists.
    Nakai T; Milusheva E; Baranyi M; Uchihashi Y; Satoh T; Vizi ES
    Eur J Pharmacol; 1999 Feb; 366(2-3):143-50. PubMed ID: 10082194
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Roles for nitric oxide as an intra- and interneuronal messenger at NMDA release-regulating receptors: evidence from studies of the NMDA-evoked release of [3H]noradrenaline and D-[3H]aspartate from rat hippocampal slices.
    Jones NM; Loiacono RE; Beart PM
    J Neurochem; 1995 May; 64(5):2057-63. PubMed ID: 7536805
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CGP 37849 and CGP 39551: novel and potent competitive N-methyl-D-aspartate receptor antagonists with oral activity.
    Fagg GE; Olpe HR; Pozza MF; Baud J; Steinmann M; Schmutz M; Portet C; Baumann P; Thedinga K; Bittiger H
    Br J Pharmacol; 1990 Apr; 99(4):791-7. PubMed ID: 1972895
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Binding of 3H-desipramine to the neuronal noradrenaline carrier of rat phaeochromocytoma cells (PC-12 cells).
    Bönisch H; Harder R
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Dec; 334(4):403-11. PubMed ID: 3821933
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [N-2-chloroethyl-N-ethyl-2-bromobenzylamine (DSP4) increases the liberation of 3H-noradrenaline produced by depolarization of the nerve ending].
    Landa ME; Rubio MC; Jaim-Etcheverry G
    Acta Physiol Pharmacol Latinoam; 1988; 38(2):167-80. PubMed ID: 2847491
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.